Details

---

• Active Ingredients: Each 2.5 mL respule contains 500 mcg of ipratropium bromide and 2.5 mg of salbutamol sulfate.

• Manufacturer: Cipla Ltd, India.

• Registration in Malaysia: Registered with the National Pharmaceutical Regulatory Agency (NPRA) under registration number MAL19980100AZ.

Indications

• Chronic Obstructive Pulmonary Disease (COPD): For patients who continue to experience bronchospasm despite regular use of a single bronchodilator.

• Bronchospasm Relief: To alleviate symptoms such as wheezing, chest tightness, and shortness of breath.

Instructions for Use

• Dosage: One respule (2.5 mL) to be inhaled 3 to 4 times daily, as directed by a healthcare professional. 

• Administration: Use only with a suitable nebulizer. Do not swallow or inject.

• Storage: Store below 25°C. Do not freeze. Keep in a vertical position and protect from light.